Biology

Lovelace Biomedical Represented at Capitol Hill for Early-Career National Day of Action, With the American Association for Cancer Research


Today is the Early-career National Day of Action and we’re proud to have Loryn Phillips, one of our Research Lab Technicians, up on Capitol Hill rallying support from members of congress to keep

Lauryn Hill, Research Lab Technician

funding NIH research. #AACRonthehill

 

Loryn graduated from the University of New Mexico in 2019 with a Bachelor of Science in Biology with a concentration in Biotechnology. She interned with NASA at Stennis Space Center and is the president of Christian Women in Science, an affiliate of American Scientific Association. Loryn has worked primarily as a laboratory technician at Lovelace Respiratory Research Institute in the lung cancer department. Her work has involved studying health effects of tobacco products and NIH funded grants. Currently, Loryn is working on her masters at University of New Mexico. Her research is focusing on potential biomarkers in lung cancer.

Read more below on what Loryn is doing with the American Association for Cancer Research (AACR).in


WHAT:

The American Association for Cancer Research (AACR) will send 16 early-career cancer scientists from across the United States to Capitol Hill to meet with more than 50 members of Congress and their staff, representing 18 different states, as part of the fifth annual AACR Early-career Hill Day.

WHEN:

Feb. 27, 2020

WHERE:

Capitol Hill, Washington, D.C.

WHO:

  • Early-career investigators who conduct cancer research in institutions across the country. A full list is available on the AACR’s website.
  • Katerina Politi, PhD, Associate Professor of Pathology; Co-leader, Cancer Signaling Networks, Yale Cancer Center. Politi is serving as the Scientist Mentor for the Hill Day.

During these congressional visits, the early-career scientists will call on members of Congress to keep funding for medical research a priority and support a $3 billion increase for the National Institutes of Health (NIH) in fiscal year (FY) 2021. As the investigators whose careers may be most impacted by this funding, Hill Day participants are able to provide personal testimony and real-world examples of its importance.

In conjunction with the Hill Day on Feb. 27, the AACR is inviting early-career scientists around the country to participate in a National Day of Action by contacting their members of Congress via email or social media. The AACR has launched a campaign through its Legislative Action Center for sending emails to Congress. Early-career scientists are also encouraged to tweet messages in support of NIH funding at their members of Congress using the hashtag #AACRontheHill.

Federal funding for medical research is essential to continued progress against cancer and other diseases, and fuels a robust economy. In FY 2019, NIH funding supported more than 475,000 jobs nationwide and produced $81.2 billion in new economic activity.

In addition to the AACR Early-career Hill Day, the AACR supports and engages early-career scientists through the Associate Member Council, Science Education and Career Advancement Committee, and other Association groups, as well as through various professional advancement programs, career initiatives, grants, travel awards, and membership and mentoring opportunities available throughout the year.

Follow us at:

https://www.linkedin.com/company/lovelace-biomedical/

https://www.twitter.com/lovelacebio

The post Lovelace Biomedical Represented at Capitol Hill for Early-Career National Day of Action, With the American Association for Cancer Research appeared first on Lovelace Biomedical.



Source link

Related posts

Ribbon Cutting and Open House at Milwaukee Area Technical College on Oct. 17 to Spotlight New CNC Swiss Machinery and Expanded Instructional Capacity

Newsemia

Seasonal muscle ultrastructure plasticity and resistance of muscle structural changes during temperature increases in resident black-capped chickadees (Poecile atricapillus) and rock pigeons (Columba livia) [RESEARCH ARTICLE]

Newsemia

Trial By Error: My STAT Opinion Piece on BMJ and Dr Godlee

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World